Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting the joints and surrounding tissue. Identification of novel proteins associated with the progression of a disease is a prerequisite for understanding the pathogenesis of RA. The present study was undertaken to identify the potential biomarkers from a less explored biological sample such as synovial fluid (SF) cells which is specific for RA and to analyze their functional aspects using proteomic approach. Two-dimensional gel electrophoresis (2-DE) was performed using synovial fluid cells of RA and osteoarthritis (OA) patients, and 7 differentially expressed proteins were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS/MS). Αlpha-Taxilin (α-Taxilin) has been found as one of the novel, significantly up regulated protein in RA. It has been validated in the synovium, synovial fluid (SF), SF cells, and plasma samples by Western blot, enzyme-linked immunosorbent assay (ELISA), fluorescence-activated cell sorting (FACS), immunohistochemistry (IHC), and real-time PCR. The identification of autoantibody against α-Taxilin and in silico studies has further helped us to understand its involvement in disease mechanism. The present study will therefore provide knowledge towards the etiology of RA that pave the way for suitable prognostic marker identification along with other clinical parameters.
Highlights
Rheumatoid arthritis (RA) is the most common chronic, systemic inflammatory autoimmune disease affecting around 1% of the population worldwide [1, 2]
After performing densitometric analysis of the 2.3. Two-Dimensional Gel Electrophoresis (2-DE) gel image, we found that α-Taxilin is one of the significantly upregulated (2.4) RASF cells compared to OASF cells
Expression of α-Taxilin has been found to increase by 1.52-fold and 1.35-fold in RA plasma compared to HC plasma and OA plasma (p ≤ 0:048), respectively
Summary
Rheumatoid arthritis (RA) is the most common chronic, systemic inflammatory autoimmune disease affecting around 1% of the population worldwide [1, 2]. Tumor Necrosis Factor (TNF), IL-6, anticyclic citrullinated peptide (anti-CCP), rheumatoid factor (RF), and antimannose binding lectin [9] (anti-MBL) are helpful in diagnosing the disease to a certain extent. These antigens are not specific whether they initiate autoimmune reactions, making the diagnosis critical [8, 10]. Since the specific site of inflammation plays a vital role in the disease
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have